New data from vaxart oral covid-19 vaccine phase i study suggests broad cross-reactivity against other coronaviruses

Vaxart oral vaccine induced higher cd8 + t-cell responses than those seen with moderna or pfizer vaccines in comparative experiment conducted by the company

VXRT Ratings Summary

VXRT Quant Ranking